PulseAugur
EN
LIVE 21:49:06

Theranos 2.0? Billy Evans launches AI blood test startup Haemanthus

By PulseAugur Editorial · [1 sources] ·

Billy Evans, previously described as "repugnant in his cockiness" by Variety, is launching a new startup called Haemanthus. This company aims to develop an AI-powered wearable blood test, drawing parallels to the failed Theranos venture. Evans, who lacks a background in this specific field, is reportedly leading this new endeavor. AI

IMPACT This venture's success could influence the integration of AI in health diagnostics, but its parallels to Theranos raise significant skepticism.

RANK_REASON The cluster describes the launch of a new product/company, but it is not from a frontier AI lab and lacks significant industry-wide impact.

Read on Mastodon — mastodon.social →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Theranos 2.0? Billy Evans launches AI blood test startup Haemanthus

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Tool
The cluster describes the launch of a new product/company, but it is not from a frontier AI lab and lacks significant industry-wide impact.
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
product, other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Standard
On-topic for AI-industry coverage; kept in the public index.
Story freshness
1 days old
Coverage has settled into its steady-state source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. Mastodon — mastodon.social TIER_1 English(EN) · [email protected] ·

    Managing VC funded companies in the US is largely a revolving door sport played by wealthy families. Even Variety review referred to Billy Evans as "repugnant i

    Managing VC funded companies in the US is largely a revolving door sport played by wealthy families. Even Variety review referred to Billy Evans as "repugnant in his cockiness" so naturally THAT guy is starting Theranos 2.0. The new company is called Haemanthus and will be using …

    LINKS fortune.com/…/theranos-elizabeth-holmes-b…

RELATED ENTITIES

RELATED TOPICS